|
UBR5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.704800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.927820E-02 |
| Normal-vs-Stage2 |
1.684720E-03 |
| Normal-vs-Stage3 |
6.776100E-04 |
| Normal-vs-Stage4 |
4.056400E-02 |
| Stage1-vs-Stage2 |
5.018400E-02 |
| Stage1-vs-Stage3 |
6.725900E-02 |
| Stage1-vs-Stage4 |
9.085800E-01 |
| Stage2-vs-Stage3 |
5.332800E-01 |
| Stage2-vs-Stage4 |
1.123370E-01 |
| Stage3-vs-Stage4 |
1.870790E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.155700E-03 |
| Normal-vs-AfricanAmerican |
6.099000E-01 |
| Normal-vs-Asian |
2.635800E-01 |
| Caucasian-vs-AfricanAmerican |
1.700820E-01 |
| Caucasian-vs-Asian |
1.870170E-01 |
| AfricanAmerican-vs-Asian |
7.202800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.521500E-03 |
| Normal-vs-Female |
3.344700E-03 |
| Male-vs-Female |
8.731000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.237900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.900300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.458700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.431800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.591900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.052500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.152100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.270800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.687000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.341600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.206300E-02 |
| Classical-VS-Follicular |
3.779700E-03 |
| Classical-VS-Other |
9.349600E-01 |
| Classical-VS-Normal |
8.029900E-02 |
| Tall-VS-Follicular |
5.138200E-01 |
| Tall-VS-Other |
4.280800E-01 |
| Tall-VS-Normal |
8.043900E-03 |
| Follicular-VS-Other |
3.906800E-01 |
| Follicular-VS-Normal |
3.774500E-04 |
| Other-VS-Normal |
4.304600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.435200E-04 |
| Normal-vs-N1 |
1.476040E-02 |
| N0-vs-N1 |
5.673000E-01 |
|
|
